- By William Silgueiro
- (General Dispatch) – According to information provided by the European Union’s Medicines Regulatory Agency, a possible link between the Astrazeneca vaccine and the formation of blood clots in the body has been detected.
- Through a press release this Wednesday, the European Agency published the determination of the theory that for weeks had been questioned. Indicating that although there is a possible link, the effectiveness of the vaccine outweighs all the risks.
- Likewise, the study indicates that the great majority of pathologies have been evidenced in women under sixty years of age. After having received the administration of the first dose of the vaccine.
- Specialists in the area of research assured that the patients whose pathologies presented the formulation of clots come from the United Kingdom and Europe where at least 25 million people have been vaccinated by the Astrazeneca brand.
- Although the WHO has assured that the vaccine is highly effective, many people continue to question its safety.
- In the meantime, EMA will soon announce the official results of the research, since, so far, only some scientific advances are known. This will be necessary to reduce the level of public distrust.
- In the meantime, as the number of infections and deaths is increasing proportionally across Europe, the new covid-19 variations from Great Britain are beginning to have an effect.
- So far, the countries of the European Union are still waiting for the arrival of a large batch of vaccine to meet the demand. And to finally stop the effects of the coronavirus.
Adittional Information:
Breitbart: UK Regulator Urges People to Keep Taking AstraZeneca Vax Despite Blood Clot Claims
BBC: EU drug regulator: Unusual blood clot is ‘very rare AstraZeneca side effect’
